{"filing":{"accession_number":"0001104659-26-064761","cik":"0001828185","ticker":"BRNS","company_name":"Barinthus Biotherapeutics plc.","form":"8-K","filing_date":"2026-05-21","report_date":null,"primary_document":"tm2615235d1_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1828185/000110465926064761/tm2615235d1_8k.htm"},"events":[{"id":9304,"run_id":8161,"accession_number":"0001104659-26-064761","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"This Item 5.07 filing discloses the results of two shareholder votes held on May 20, 2026: a Court Meeting of Scheme Shares and a General Meeting of shareholders, both approving a Scheme of Arrangement (a merger/acquisition transaction). The overwhelming approval rates (99.98% in favor at both meetings) and the explicit statement that \"All matters submitted to a vote of the Company's stockholders...were approved\" directly match the shareholder_vote_results event type. This is material as it represents shareholder approval of a significant corporate transaction.","company_name":"Barinthus Biotherapeutics plc.","ticker":"BRNS","filing_date":"2026-05-21","form":"8-K","submitted_at":null,"items":[{"id":892,"accession_number":"0001104659-26-064761","item_number":"5.07","item_title":"Submission of Matters to","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This Item 5.07 filing discloses the results of two shareholder votes held on May 20, 2026: a Court Meeting of Scheme Shares and a General Meeting of shareholders, both approving a Scheme of Arrangement (a merger/acquisition transaction). The overwhelming approval rates (99.98% in favor at both meetings) and the explicit statement that \"All matters submitted to a vote of the Company's stockholders...were approved\" directly match the shareholder_vote_results event type. This is material as it represents shareholder approval of a significant corporate transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:30:45.710374+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":892,"accession_number":"0001104659-26-064761","item_number":"5.07","item_title":"Submission of Matters to","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This Item 5.07 filing discloses the results of two shareholder votes held on May 20, 2026: a Court Meeting of Scheme Shares and a General Meeting of shareholders, both approving a Scheme of Arrangement (a merger/acquisition transaction). The overwhelming approval rates (99.98% in favor at both meetings) and the explicit statement that \"All matters submitted to a vote of the Company's stockholders...were approved\" directly match the shareholder_vote_results event type. This is material as it represents shareholder approval of a significant corporate transaction.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:30:45.710374+00:00","company_name":"Barinthus Biotherapeutics plc.","ticker":"BRNS","filing_date":"2026-05-21"}]}